BIBLIOGRAFÍA
1. Hart J, Mandavilli S. Epithelioid angiosarcoma. A brief review and differential diagnosis. Arch Pathol Lab Med 2011; 135:261-72.
2. Pacheco C, Albalá MD, Blanco M, Hidalgo FJ. Angiosarcoma epitelioide óseo multifocal con metástasis pulmonares. Radiología 2012; 12:1-4.
3. Pirayesh A, Chee Y, Heliwell R, Hershman M, Leinster S, Fordham M, Poston G. The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. EJSO 2001; 27:491-97.
4. D`Adamo DR, Anderson SE, Albritton K. Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas. J Clin Oncol. 2005; 23:7135-42.
5. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, et-al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1995; 13:1537-45.
6. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400-6.
7. Budd GT. Management of angiosarcoma. Curr Oncol Rep. 2002;4:515-9.